Composites World / NetComposites

Connecting you to the composites industry

Advertisement

NetComposites Ltd has transferred the rights and ownership of this website to Gardner Business Media Inc.

On 1st January 2020, NetComposites' media assets including netcomposites.com, newsletters and conferences were transferred to Composites World (Gardner Business Media).

This site is no longer being updated. Please direct all enquiries to netcomposites@gardnerweb.com.

For further details see our joint press release.

DSM Close Flaach Tape Development & Manufacturing Facility

  • Tuesday, 3rd January 2012
  • 0 comments
  • Reading time: about 2 minutes

DSM Dyneema has decided to close its facility in Flaach, Switzerland, a site that was acquired in 2007 as part of the acquisition of Pamako, and currently develops and produces Ultra-High Molecular Weight Polyethylene (UHMwPE) tape.

“It is with regret that we have taken this decision today for the people involved,”said Gerard de Reuver, President DSM Dyneema. “We have invested considerable resources in improving the technology and capabilities of the people involved over the last few years. With great support from our R&D team, the crew in Flaach has worked exceptionally hard to commercialise new products. The economics of the site were always a challenge. It is a very small site and the operational costs for a separate development facility have become unacceptable, especially in the current economic circumstances.” DSM is supporting all affected employees to find alternative employment.

DSM explain that since acquiring the business, they have extensively developed the process and commercialised the first UHMwPE tape grade for ballistic applications in 2008, with further products announced since then for several new applications including telecommunications. A major new tape manufacturing facility is approaching completion on the existing DSM Dyneema site in Greenville, North Carolina, in the US.


For more information visit:


Share this article


More News


Comments (0)

Leave your comment